ArticleAfrican journal of emergency medicine : Revue africaine de la medecine d'urgence2021
Drop for drop: A descriptive analysis of blood product usage in a South African tertiary care setting during the Covid-19 pandemic.
Article in African journal of emergency medicine : Revue africaine de la medecine d'urgence, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- COVID-19 impact on blood donation and blood product use in Mangaung Metropolitan Municipality.South African family practice : official journal of the South African Academy of Family Practice/Primary Care · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe Covid-19 pandemic has had a drastic effect on the global community. Blood products are precious resources especially in the African context and this has been especially compounded during the Covid-19 pandemic. Concurrent to this during the Covid-19 level 5 lockdown in South Africa from 26 March - 30 April 2020, a decrease in trauma admissions to state hospitals was noted. The aim of this data collection was to assess whether lowered blood product issuance was seen during the Covid-19 pandemic lockdown.
methodAreas at Tygerberg Hospital with trauma patients were identified, namely: the A1W intensive care unit (Surgical ICU), Trauma Front Room (Trauma Admissions), Trauma Resuscitation unit (Trauma Resus Area) and J7(Trauma Ward). Data of blood product issuance (red blood cells and fresh frozen plasma) for these 4 areas was provided by the Western Cape Blood Service for the period 26 March-30 April 2018, 2019 and 2020. This included the stage 5 Covid-19 South African lockdown, as well as Easter for all three years which is traditionally associated with raised trauma admissions. This data was quantitative.
results201 products were issued in 2018 versus 103 for the same period in 2020 for the 4 trauma areas in Tygerberg Hospital. The surgical ICU received the most products over 3 years with 183 of the product issuances. DISCUSSION: As expected there was a significant decrease in blood product (red blood cell and fresh frozen plasma) issuance during the 2020 period which paralleled the lowered trauma numbers. This represented a significant cost saving of over R150 000 despite increased yearly costs for blood products over the same period. This data collection did not consider the reasoning for these blood transfusions or the clinical appropriateness thereof. The author acknowledges the wide variability of transfusion thresholds and protocols within various centres around the world, including Tygerberg and was not seeking to prove commentary on the appropriateness thereof in this research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.